Dr. Reddy's Laboratories informed that the audit of formulations manufacturing plants (Vizag SEZ Plant 1 and Vizag SEZ Plant 2) at Duvvada, Visakhapatnam by the US FDA, has been completed on 21 June 2019. The company was issued a Form 483 with two observations. The announcement was made on Saturday, 22 June 2019.
